Publications dans lesquelles il/elle collabore avec Beatriz Ramirez Sola (21)

2018

  1. Clinical usefulness of abdominal bioimpedance (ViScan) in the determination of visceral fat and its application in the diagnosis and management of obesity and its comorbidities

    Clinical Nutrition, Vol. 37, Núm. 2, pp. 580-589

2017

  1. Dissociation of body mass index, excess weight loss and body fat percentage trajectories after 3 years of gastric bypass: Relationship with metabolic outcomes

    International Journal of Obesity, Vol. 41, Núm. 9, pp. 1379-1387

  2. IL-32α-induced inflammation constitutes a link between obesity and colon cancer

    OncoImmunology, Vol. 6, Núm. 7

2015

  1. Expression of S6K1 in human visceral adipose tissue is upregulated in obesity and related to insulin resistance and inflammation

    Acta Diabetologica, Vol. 52, Núm. 2, pp. 257-266

2014

  1. Activation of noncanonical wnt signaling through WNT5A in visceral adipose tissue of obese subjects is related to inflammation

    Journal of Clinical Endocrinology and Metabolism, Vol. 99, Núm. 8

  2. Comparative effects of gastric bypass and sleeve gastrectomy on plasma osteopontin concentrations in humans

    Surgical Endoscopy, Vol. 28, Núm. 8, pp. 2412-2420

2013

  1. Increased levels of chemerin and its receptor, chemokine-like receptor-1, in obesity are related to inflammation: Tumor necrosis factor-α stimulates mRNA levels of chemerin in visceral adipocytes from obese patients

    Surgery for Obesity and Related Diseases, Vol. 9, Núm. 2, pp. 306-314

  2. Six-transmembrane epithelial antigen of prostate 4 and neutrophil gelatinase-associated lipocalin expression in visceral adipose tissue is related to iron status and inflammation in human obesity

    European Journal of Nutrition, Vol. 52, Núm. 6, pp. 1587-1595

2012

  1. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity

    International Journal of Obesity, Vol. 36, Núm. 2, pp. 286-294

  2. Clinical usefulness of a new equation for estimating body fat

    Diabetes Care, Vol. 35, Núm. 2, pp. 383-388

  3. Estudio de la utilidad de la bioimpedancia en la determinación de la grasa visceral y su aplicación en el diagnóstico y tratamiento de la obesidad y sus comorbilidades

    Anales del sistema sanitario de Navarra, Vol. 35, Núm. 1, pp. 183-184

  4. Increased tenascin C and toll-like receptor 4 levels in visceral adipose tissue as a link between inflammation and extracellular matrix remodeling in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 97, Núm. 10

2011

  1. Association of increased Visfatin/PBEF/NAMPT circulating concentrations and gene expression levels in peripheral blood cells with lipid metabolism and fatty liver in human morbid obesity

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 21, Núm. 4, pp. 245-253

  2. Body adiposity and type 2 diabetes: Increased risk with a high body fat percentage even having a normal BMI

    Obesity, Vol. 19, Núm. 7, pp. 1439-1444

  3. Increased circulating and visceral adipose tissue expression levels of YKL-40 in obesity-associated type 2 diabetes are related to inflammation: impact of conventional weight loss and gastric bypass

    Journal of Clinical Endocrinology and Metabolism, Vol. 96, Núm. 1, pp. 200-209

  4. Increased levels of calprotectin in obesity are related to macrophage content: Impact on inflammation and effect of weight loss

    Molecular Medicine, Vol. 17, Núm. 11, pp. 1157-1167

  5. Up-regulation of the novel proinflammatory adipokines lipocalin-2, chitinase-3 like-1 and osteopontin as well as angiogenic-related factors in visceral adipose tissue of patients with colon cancer

    Journal of Nutritional Biochemistry, Vol. 22, Núm. 7, pp. 634-641

2009

  1. Increased adipose tissue expression of lipocalin-2 in obesity is related to inflammation and matrix metalloproteinase-2 and metalloproteinase-9 activities in humans

    Journal of Molecular Medicine, Vol. 87, Núm. 8, pp. 803-813

2008

  1. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass

    Clinical Endocrinology, Vol. 69, Núm. 2, pp. 208-215

2007

  1. Plasma osteopontin levels and expression in adipose tissue are increased in obesity

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 9, pp. 3719-3727